Modulation of the immunosuppressive activities by blastocoelic fluid during rabbit pregnancy.
Temporal variation in immunosuppressive activity was determined in biological samples such as embryo-foetal fluids (blastocoelic- or amino-allantoic fluid) and blood collected from pregnant and pseudopregnant rabbits. Each of the fluids to be analyzed was pre-incubated with mitogen stimulated human lymphocytes for 48 h and then inhibition of [3H]thymidine incorporation or IL-2 receptor expression was estimated. Both means of assessing immunosuppression indicated variations in the suppressive activity throughout pregnancy. This was observed in embryo-foetal fluids but not in autologous peripheral blood nor in homologous pseudopregnant blood. At days 9-13 of pregnancy, the immunosuppressive effects of blastocoelic fluids were higher than that of the autologous sera, reached a peak at days 12 and 13 and declined thereafter, to reach the lowest levels. In order to further characterize the biological activity of day-12 blastocoelic fluid and autologous serum, they were submitted to ultracentrifugation. No suppressive activity could be demonstrated in the lipoprotein fractions. But all the activity was found in the protein fraction. Precipitation with cold ethanol confirmed that the biologically active compound was a protein. Furthermore, results obtained after ultrafiltration suggest biologically active compounds of high mol. wt (greater than 300 kDa). From the above findings, we can suggest that in the rabbit, there is no pregnancy specific systemic immunosuppression. We can also infer that (1) the immuno-tolerance of the mother towards the embryo is more due to a localized effect; (2) this effect decreases with the progression of gestation and (3) a high mol. wt factor is responsible for the immunosuppression.
Lambert
R D
RD
Ontogénie et Reproduction, Laval University Medical Center, Ste-Foy, Québec, Canada.
Roy
R
R
Morin
C
C
Beaudoin
J
J
Langlais
J
J
Pandian
A M
AM
D000482:Allantois / Q000032:analysis; D000818:Animals; D001755:Blastocyst / Q000032:analysis*; D001826:Body Fluids / Q000032:analysis; D005260:Female; D005865:Gestational Age; D007108:Immune Tolerance; D066298:In Vitro Techniques; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000276:immunology*; D011555:Pseudopregnancy / Q000276:immunology; D011817:Rabbits; D015375:Receptors, Interleukin-2 / Q000032:analysis; D013491:Suppressor Factors, Immunologic / Q000032:analysis* / Q000302:isolation & purification; D013936:Thymidine / Q000378:metabolism; D014461:Ultracentrifugation
D015375:Receptors, Interleukin-2; D013491:Suppressor Factors, Immunologic; D013936:Thymidine